Actualizado 18/06/2007 12:03
- Comunicado -

New Study Shows That telmisartan has Greater Renoprotective Potential Than losartan in Hypertensive Patients With Type 2

8. Brunner HR. J Hum Hypertens 2002;16(suppl 2):S13-S16.

9. Neutel JM, Smith HG. J Clin Hypertens 2003;5(1):58-63.

10. Millar-Craig MW et al. Lancet 1978;1:795-97.

Contact Dr. Reinhard Malin, Corporate Division Communications, Boehringer Ingelheim GmbH, 55216 Ingelheim/Germany, Phone: +49-6132 -77-90815, Fax: +49-6132-72-6601, E-mail: press@boehringer-ingelheim.com

Contenido patrocinado